Transformative Innovations in global health

Last updated: 16.7.2025
Grant

The 'Transformative Innovations in global health' program, part of Horizon Europe and managed by the Global Health EDCTP3 Joint Undertaking, aims to foster groundbreaking solutions for infectious diseases, including HIV/AIDS. This initiative specifically targets the development of more accessible, affordable, and patient-centric health technologies and services, with a strong focus on benefiting vulnerable populations and commercially unattractive markets in sub-Saharan Africa.

Who is Funded for Global Health Innovations

The 'Transformative Innovations in global health' program is designed to support a wide range of entities committed to advancing global health. Funding is primarily directed towards research and innovation efforts that address critical unmet needs in infectious diseases, ensuring that solutions are both accessible and affordable, especially in underserved regions.

What Research and Innovation is Funded

This section details the specific types of projects and thematic areas that are eligible for funding under the 'Transformative Innovations in global health' program. It outlines the focus on infectious diseases and the developmental stages of projects that the program aims to support, from beyond proof-of-concept to potential commercialization.

Type and Scope of Funding

This section outlines the financial characteristics of the 'Transformative Innovations in global health' program, detailing the type of financial support provided and the funding amounts available per project, emphasizing a clear framework for financial planning.

Conditions and Requirements for Applicants

This section provides essential conditions and requirements for applicants and beneficiaries under the 'Transformative Innovations in global health' program, covering application terms, consortium rules, and specific provisions for project implementation and exploitation.

Application Procedure

This section outlines the procedural steps for submitting an application to the 'Transformative Innovations in global health' program, detailing the submission process, evaluation methods, and notification of award decisions. It provides guidance on required forms and relevant manuals.

This section establishes the foundational legal framework and guiding documents for the 'Transformative Innovations in global health' program, ensuring transparency and adherence to established European Union regulations and policies.

Similar Programs

#Global health innovation#Infectious diseases research#Accessible health solutions#EDCTP3 funding#Diagnostics#Vaccines#Patient-centric treatments#Sub-Saharan Africa#Technology transfer#Clinical studies#Health technologies#Horizon Europe#Disruptive innovation#Medical development#Affordable healthcare

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

2,100,000 €

Allocated Budget

Allocated Budget:

17,100,000 €

Open Until

Open Until:

2027

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union Member States, Overseas Countries and Territories (OCTs) linked to Member States, Countries associated to Horizon Europe, Countries with ongoing Horizon Europe association negotiations (Morocco, South Korea, Switzerland), and Sub-Saharan African countries that are members of the EDCTP Association. The focus is on global health, particularly in sub-Saharan Africa.

Sectors

Sectors:

Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Other

Beneficiaries

Beneficiaries:

Research and innovation in global health, infectious diseases

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Experimental Development, Prototyping, Pilot Testing, Product Development, Commercialization

Funding Provider

Program Level:

European Union

Funding Body:

Global Health EDCTP3 Joint Undertaking (JU)

Managed By:

Global Health EDCTP3 Joint Undertaking (JU)

0 x 0
XS